MedPath

Assessing the diaphragm before and after Endobronchial Valve Treatment

Completed
Conditions
COPD emphysema
10038716
Registration Number
NL-OMON52012
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

1)Patient is scheduled for a bronchoscopic lung volume treatment using one-way
valves
2)Patient read, understood and signed the Informed Consent Form

Exclusion Criteria

There are no exclusion criteria for this study.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Change in diaphragm function 6 week after EBV treatment measured by ultrasound.<br /><br>The main outcome will be diaphragm motion (difference between maximum in- and<br /><br>expiration).</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath